KEVIN C TANG Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for KEVIN C TANG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KEVIN C TANG. KEVIN C TANG is Director in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and Director in LA JOLLA PHARMACEUTICAL CO ($LJPC) and 10% Owner in Cyclacel Pharmaceuticals, Inc. ($CYCC) and 10% Owner in Aptevo Therapeutics Inc. ($APVO) and Chief Executive Officer in Odonate Therapeutics, Inc. ($ODT).
Latest Insider Trading Transactions of KEVIN C TANG
Sentiment: All, APVO, CYCC, HRTX, LJPC, ODT
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 20 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 20.08 | 10,000 | 200,788 | 12,572,338 | 12.6 M to 12.6 M (+0.08 %) |
Sep 20 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 19.75 | 7,983 | 157,681 | 12,562,338 | 12.6 M to 12.6 M (+0.06 %) |
Sep 20 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 19.75 | 7,983 | 157,681 | 12,562,338 | 12.6 M to 12.6 M (+0.06 %) |
Sep 20 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 19.48 | 2,017 | 39,288 | 12,554,355 | 12.6 M to 12.6 M (+0.02 %) |
Sep 20 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 19.48 | 2,017 | 39,288 | 12,554,355 | 12.6 M to 12.6 M (+0.02 %) |
Sep 20 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 19.31 | 10,000 | 193,086 | 12,552,338 | 12.5 M to 12.6 M (+0.08 %) |
Sep 20 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 19.31 | 10,000 | 193,086 | 12,552,338 | 12.5 M to 12.6 M (+0.08 %) |
Sep 20 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 19.42 | 10,000 | 194,161 | 12,542,338 | 12.5 M to 12.5 M (+0.08 %) |
Sep 20 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 19.42 | 10,000 | 194,161 | 12,542,338 | 12.5 M to 12.5 M (+0.08 %) |
Sep 20 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 19.30 | 10,000 | 192,982 | 12,532,338 | 12.5 M to 12.5 M (+0.08 %) |
Sep 20 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 19.30 | 10,000 | 192,982 | 12,532,338 | 12.5 M to 12.5 M (+0.08 %) |
Sep 20 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 19.03 | 10,000 | 190,290 | 12,522,338 | 12.5 M to 12.5 M (+0.08 %) |
Sep 20 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 19.03 | 10,000 | 190,290 | 12,522,338 | 12.5 M to 12.5 M (+0.08 %) |
Sep 20 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 19.34 | 10,000 | 193,366 | 12,512,338 | 12.5 M to 12.5 M (+0.08 %) |
Sep 20 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 19.34 | 10,000 | 193,366 | 12,512,338 | 12.5 M to 12.5 M (+0.08 %) |
Sep 20 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 19.34 | 10,000 | 193,387 | 12,502,338 | 12.5 M to 12.5 M (+0.08 %) |
Sep 20 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 19.34 | 10,000 | 193,387 | 12,502,338 | 12.5 M to 12.5 M (+0.08 %) |
Sep 12 2018 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Sell | S | 35.75 | 2,695,000 | 96,346,250 | 5,830,215 | 8.5 M to 5.8 M (-31.61 %) |
Aug 23 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 19.47 | 7,505 | 146,151 | 12,492,338 | 12.5 M to 12.5 M (+0.06 %) |
Aug 20 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 18.96 | 10,108 | 191,613 | 12,484,833 | 12.5 M to 12.5 M (+0.08 %) |
Aug 20 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 19.26 | 2,387 | 45,980 | 12,474,725 | 12.5 M to 12.5 M (+0.02 %) |
Aug 20 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 19.80 | 20,000 | 396,098 | 12,472,338 | 12.5 M to 12.5 M (+0.16 %) |
Aug 20 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 19.46 | 17,190 | 334,583 | 12,452,338 | 12.4 M to 12.5 M (+0.14 %) |
Aug 15 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 18.86 | 2,810 | 52,992 | 12,435,148 | 12.4 M to 12.4 M (+0.02 %) |
Aug 15 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 19.11 | 6,606 | 126,251 | 12,432,338 | 12.4 M to 12.4 M (+0.05 %) |
Aug 15 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 18.98 | 6,603 | 125,352 | 12,425,732 | 12.4 M to 12.4 M (+0.05 %) |
Aug 15 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 18.72 | 6,791 | 127,111 | 12,419,129 | 12.4 M to 12.4 M (+0.05 %) |
Apr 02 2018 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Buy | P | 26.00 | 192,308 | 5,000,008 | 8,525,215 | 8.3 M to 8.5 M (+2.31 %) |
Mar 19 2018 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 29.50 | 508,474 | 14,999,983 | 4,138,893 | 3.6 M to 4.1 M (+14.01 %) |
Mar 02 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 27.61 | 4,401 | 121,499 | 12,412,338 | 12.4 M to 12.4 M (+0.04 %) |
Mar 02 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 27.04 | 5,599 | 151,376 | 12,407,937 | 12.4 M to 12.4 M (+0.05 %) |
Mar 02 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 27.73 | 4,050 | 112,307 | 12,402,338 | 12.4 M to 12.4 M (+0.03 %) |
Mar 02 2018 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 30.44 | 10,000 | 304,435 | 3,630,419 | 3.6 M to 3.6 M (+0.28 %) |
Mar 02 2018 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 30.15 | 10,000 | 301,540 | 3,620,419 | 3.6 M to 3.6 M (+0.28 %) |
Mar 02 2018 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 30.12 | 10,000 | 301,171 | 3,610,419 | 3.6 M to 3.6 M (+0.28 %) |
Mar 02 2018 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 29.54 | 10,000 | 295,381 | 3,600,419 | 3.6 M to 3.6 M (+0.28 %) |
Feb 22 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 27.96 | 7,338 | 205,182 | 12,369,676 | 12.4 M to 12.4 M (+0.06 %) |
Feb 22 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 27.29 | 10,000 | 272,883 | 12,362,338 | 12.4 M to 12.4 M (+0.08 %) |
Feb 22 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 27.95 | 10,000 | 279,535 | 12,352,338 | 12.3 M to 12.4 M (+0.08 %) |
Feb 22 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 27.72 | 3,432 | 95,125 | 12,342,338 | 12.3 M to 12.3 M (+0.03 %) |
Feb 22 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 25.15 | 8,313 | 209,086 | 12,338,906 | 12.3 M to 12.3 M (+0.07 %) |
Feb 16 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 24.54 | 8,255 | 202,553 | 12,330,593 | 12.3 M to 12.3 M (+0.07 %) |
Feb 16 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 24.37 | 20,000 | 487,420 | 12,322,338 | 12.3 M to 12.3 M (+0.16 %) |
Feb 16 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 23.72 | 29,109 | 690,474 | 12,302,338 | 12.3 M to 12.3 M (+0.24 %) |
Feb 16 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 21.98 | 34,943 | 768,075 | 12,273,229 | 12.2 M to 12.3 M (+0.29 %) |
Feb 16 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 20.39 | 35,948 | 732,822 | 12,238,286 | 12.2 M to 12.2 M (+0.29 %) |
Dec 20 2017 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Option Exercise | A | 17.00 | 17,000 | 289,000 | 17,000 | |
Dec 13 2017 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Option Exercise | A | 28.10 | 10,000 | 281,000 | 10,000 | |
Dec 08 2017 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 24.00 | 1,291,666 | 30,999,984 | 12,202,338 | 10.9 M to 12.2 M (+11.84 %) |
Mar 27 2017 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 33.50 | 149,254 | 5,000,009 | 3,440,419 | 3.3 M to 3.4 M (+4.53 %) |
Feb 27 2017 | CYCC | Cyclacel Pharmaceu ... | TANG KEVIN C | 10% Owner | Buy | P | 4.34 | 134,200 | 582,079 | 559,900 | 425.7 K to 559.9 K (+31.52 %) |
Jan 23 2017 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Buy | P | 12.20 | 2,459,016 | 29,999,995 | 8,332,907 | 5.9 M to 8.3 M (+41.86 %) |
Jan 06 2017 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Option Exercise | A | 19.19 | 10,000 | 191,900 | 10,000 | |
Dec 23 2016 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Option Exercise | A | 13.00 | 17,000 | 221,000 | 17,000 | |
Sep 13 2016 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 20.28 | 16,448 | 333,514 | 3,191,165 | 3.2 M to 3.2 M (+0.52 %) |
Sep 13 2016 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 19.92 | 22,587 | 449,886 | 3,174,717 | 3.2 M to 3.2 M (+0.72 %) |
Sep 13 2016 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 19.72 | 100,000 | 1,971,970 | 3,152,130 | 3.1 M to 3.2 M (+3.28 %) |
Jun 20 2016 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Option Exercise | M | 3.60 | 1,250,000 | 4,500,000 | 0 | |
Jun 20 2016 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Payment of Exercise | F | 18.47 | 243,639 | 4,500,012 | 5,873,891 | 6.1 M to 5.9 M (-3.98 %) |
Jun 20 2016 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Buy | M | 3.60 | 1,250,000 | 4,500,000 | 6,117,530 | 4.9 M to 6.1 M (+25.68 %) |
Mar 08 2016 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 19.85 | 20,000 | 396,928 | 3,052,130 | 3 M to 3.1 M (+0.66 %) |
Mar 03 2016 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 18.93 | 20,000 | 378,560 | 3,032,130 | 3 M to 3 M (+0.66 %) |
Mar 03 2016 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 18.55 | 20,000 | 370,906 | 3,012,130 | 3 M to 3 M (+0.67 %) |
Mar 03 2016 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 18.72 | 20,000 | 374,488 | 2,992,130 | 3 M to 3 M (+0.67 %) |
Mar 03 2016 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 18.91 | 13,500 | 255,280 | 2,972,130 | 3 M to 3 M (+0.46 %) |
Mar 03 2016 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 18.77 | 6,500 | 121,985 | 2,958,630 | 3 M to 3 M (+0.22 %) |
Mar 03 2016 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 18.08 | 20,000 | 361,528 | 2,952,130 | 2.9 M to 3 M (+0.68 %) |
Mar 03 2016 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 17.86 | 4,028 | 71,926 | 2,932,130 | 2.9 M to 2.9 M (+0.14 %) |
Mar 03 2016 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 16.94 | 15,972 | 270,598 | 2,928,102 | 2.9 M to 2.9 M (+0.55 %) |
Mar 03 2016 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 16.13 | 20,000 | 322,502 | 2,912,130 | 2.9 M to 2.9 M (+0.69 %) |
Mar 03 2016 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 16.19 | 20,000 | 323,714 | 2,892,130 | 2.9 M to 2.9 M (+0.70 %) |
Dec 24 2015 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Option Exercise | A | 29.41 | 17,000 | 499,970 | 17,000 | |
Dec 23 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Option Exercise | A | 28.24 | 10,000 | 282,400 | 10,000 | |
Sep 14 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 38.00 | 80,000 | 3,040,000 | 2,872,130 | 2.8 M to 2.9 M (+2.87 %) |
Aug 21 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 29.94 | 10,000 | 299,413 | 2,792,130 | 2.8 M to 2.8 M (+0.36 %) |
Aug 21 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 28.25 | 10,000 | 282,505 | 2,782,130 | 2.8 M to 2.8 M (+0.36 %) |
Aug 21 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 27.82 | 10,000 | 278,150 | 2,772,130 | 2.8 M to 2.8 M (+0.36 %) |
Aug 21 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 26.73 | 10,000 | 267,280 | 2,762,130 | 2.8 M to 2.8 M (+0.36 %) |
Aug 21 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 25.72 | 10,000 | 257,167 | 2,752,130 | 2.7 M to 2.8 M (+0.36 %) |
Aug 21 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 26.54 | 10,000 | 265,448 | 2,742,130 | 2.7 M to 2.7 M (+0.37 %) |
Aug 21 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 26.85 | 10,000 | 268,549 | 2,732,130 | 2.7 M to 2.7 M (+0.37 %) |
Aug 21 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 26.97 | 10,000 | 269,710 | 2,722,130 | 2.7 M to 2.7 M (+0.37 %) |
Aug 21 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 26.66 | 10,000 | 266,583 | 2,712,130 | 2.7 M to 2.7 M (+0.37 %) |
Aug 21 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 27.17 | 10,000 | 271,685 | 2,702,130 | 2.7 M to 2.7 M (+0.37 %) |
Aug 21 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 27.59 | 30,000 | 827,697 | 2,692,130 | 2.7 M to 2.7 M (+1.13 %) |
Aug 21 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 26.98 | 10,000 | 269,782 | 2,662,130 | 2.7 M to 2.7 M (+0.38 %) |
Aug 21 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 26.26 | 10,000 | 262,585 | 2,652,130 | 2.6 M to 2.7 M (+0.38 %) |
Aug 21 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 26.13 | 20,000 | 522,676 | 2,642,130 | 2.6 M to 2.6 M (+0.76 %) |
Jun 30 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 23.58 | 110,000 | 2,593,470 | 2,622,130 | 2.5 M to 2.6 M (+4.38 %) |
Jun 24 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 22.94 | 88,314 | 2,026,188 | 2,512,130 | 2.4 M to 2.5 M (+3.64 %) |
Jun 24 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 22.27 | 53,836 | 1,198,739 | 2,423,816 | 2.4 M to 2.4 M (+2.27 %) |
Jun 24 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 21.41 | 77,850 | 1,666,597 | 2,369,980 | 2.3 M to 2.4 M (+3.40 %) |
Jun 12 2015 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Buy | P | 24.75 | 121,212 | 2,999,997 | 4,867,530 | 4.7 M to 4.9 M (+2.55 %) |
Jun 02 2015 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Buy | P | 23.84 | 32,395 | 772,294 | 4,746,318 | 4.7 M to 4.7 M (+0.69 %) |
Jun 02 2015 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Buy | P | 19.30 | 2,380 | 45,934 | 4,713,923 | 4.7 M to 4.7 M (+0.05 %) |
Jun 02 2015 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Buy | P | 19.74 | 115,225 | 2,274,058 | 4,711,543 | 4.6 M to 4.7 M (+2.51 %) |
May 13 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 18.63 | 47,483 | 884,532 | 2,292,130 | 2.2 M to 2.3 M (+2.12 %) |
May 13 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 18.25 | 44,400 | 810,362 | 2,244,647 | 2.2 M to 2.2 M (+2.02 %) |
May 13 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 18.04 | 98,700 | 1,780,548 | 2,200,247 | 2.1 M to 2.2 M (+4.70 %) |
Feb 25 2015 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Option Exercise | A | 19.69 | 10,000 | 196,900 | 10,000 |